Hal Barron, GSK R&D chief
Building up its AI operations, GSK opens a $13M London hub with plans to woo talent now trekking to Silicon Valley
Continuing its efforts to ramp up global AI operations, GlaxoSmithKline has opened a £10 million ($13 million-plus) research base in Kings Cross, London.
The AI …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.